harrow
health
appoints
larry
van
horn
board
directors
nashville
globe
newswire
harrow
health
nasdaq
hrow
today
announced
appointment
larry
van
horn
board
directors
mark
baum
ceo
harrow
health
commented
honored
welcome
larry
harrow
health
board
directors
work
advocacy
consumer
pricing
transparency
healthcare
solutions
keeping
harrow
mission
vision
values
larry
entrepreneur
experienced
board
member
also
national
delivery
healthcare
goods
services
related
policies
advised
state
federal
lawmakers
highest
levels
confident
larry
business
acumen
policy
insights
entrepreneurial
spirit
amount
significant
contributions
harrow
subsidiary
would
like
thank
mark
entire
harrow
health
board
directors
welcoming
team
said
van
horn
excited
part
next
phase
growth
harrow
innovative
healthcare
business
strongly
believe
background
experience
working
healthcare
decision
makers
business
executives
nationwide
regarding
healthcare
policy
future
healthcare
delivery
great
service
mark
board
entire
harrow
team
eagerly
looking
forward
part
culture
innovation
harrow
look
forward
contributing
shareholder
value
good
corporate
effective
september
anthony
principi
served
harrow
health
board
directors
since
resigned
roles
company
van
horn
immediately
fill
vacancies
commenting
principi
service
harrow
board
harrow
health
chairman
robert
kammer
stated
truly
grateful
tony
contribution
commitment
harrow
past
five
years
sharp
mind
thoughtful
insight
infallible
character
helped
harrow
transform
growing
business
van
horn
van
horn
entrepreneur
board
member
leading
expert
researcher
healthcare
management
economics
nontraditional
academic
activity
spans
business
health
policy
academia
research
appeared
leading
journals
journal
health
economics
journal
law
economics
new
england
journal
medicine
journal
public
budgeting
financial
management
harvard
business
review
founder
ceo
preverity
located
nashville
tennessee
preverity
healthcare
analytic
firm
comprised
data
scientists
created
risk
prediction
platform
medical
malpractice
serving
commercial
malpractice
insurers
van
horn
extensive
board
experience
public
private
boards
since
founding
governance
committee
chair
compensation
committee
member
community
health
care
realty
trust
served
compensation
committee
chair
audit
committee
member
quorum
health
corporation
prior
taken
private
board
chair
savida
mat
opioid
treatment
company
locations
massachusetts
new
hampshire
vermont
delaware
virginia
member
ceo
council
council
capital
advisory
boards
harpeth
capital
council
capital
executive
director
health
affairs
founder
director
center
health
care
market
innovation
vanderbilt
university
also
nashville
health
care
council
fellows
program
professor
van
horn
holds
university
pennsylvania
wharton
school
master
public
health
university
rochester
harrow
health
harrow
health
nasdaq
hrow
owns
portfolio
healthcare
businesses
including
imprimisrx
nation
leading
ophthalmology
outsourcing
facility
pharmaceutical
compounding
business
company
holds
large
equity
positions
eton
pharmaceuticals
surface
pharmaceuticals
melt
pharmaceuticals
mayfield
pharmaceuticals
stowe
pharmaceuticals
visionology
companies
founded
subsidiaries
harrow
health
company
also
owns
royalty
rights
certain
drug
candidates
developed
surface
melt
mayfield
harrow
intends
create
invest
grow
paradigm
shifting
healthcare
businesses
put
patients
first
information
harrow
health
please
visit
investor
relations
section
corporate
website
clicking
statements
press
release
contains
statements
within
meaning
private
securities
litigation
reform
act
statements
release
historical
facts
may
considered
statements
statements
based
management
current
expectations
subject
risks
uncertainties
may
cause
results
differ
materially
adversely
statements
contained
herein
potential
risks
uncertainties
could
cause
actual
results
differ
predicted
include
ability
make
commercially
available
compounded
formulations
technologies
timely
manner
physician
interest
prescribing
formulations
risks
related
compounding
pharmacy
operations
ability
enter
strategic
alliances
including
arrangements
pharmacies
physicians
healthcare
organizations
development
distribution
formulations
ability
obtain
intellectual
property
protection
assets
ability
accurately
estimate
expenses
cash
burn
raise
additional
funds
necessary
risks
related
research
development
activities
projected
size
potential
market
technologies
formulations
unexpected
new
data
safety
technical
issues
regulatory
market
developments
impacting
compounding
pharmacies
outsourcing
facilities
pharmaceutical
industry
competition
market
conditions
additional
risks
uncertainties
fully
described
harrow
health
filings
securities
exchange
commission
including
annual
report
form
quarterly
reports
form
documents
may
read
free
charge
sec
web
site
undue
reliance
placed
statements
speak
date
made
except
required
law
harrow
health
undertakes
obligation
update
statements
reflect
new
information
events
circumstances
date
made
reflect
occurrence
unanticipated
events
investor
contact
ir
source
harrow
health
inc
